SCHEMBL9113917

SCHEMBL9113917

OC(c1ccccc1)c1ccc(-c2ccccn2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ OPRD1 P41143 1/20 0.47
▸ KDM4E B2RXH2 5/20 0.46
▸ LMNA P02545 4/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ CCR1 P32246 2/20 0.46
▸ CCR5 P51681 2/20 0.46
▸ CCR8 P51685 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ METAP1 P53582 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ DOHH Q9BU89 1/20 0.46
▸ P4HTM Q9NXG6 1/20 0.46
▸ CA12 O43570 1/20 0.45
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ CA14 Q9ULX7 1/20 0.45
▸ DHODH Q02127 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2424951 0.81 CYP1A2 (0.47) SMN1; SMN2OPRD1KDM4ELMNACYP1A2
SCHEMBL30989133 0.79 KDM4E (0.72) SMN1; SMN2KDM4ELMNACYP1A2CCR1
SCHEMBL30989132 0.79 KDM4E (0.72) SMN1; SMN2KDM4ELMNACYP1A2CCR1
SCHEMBL1566968 0.79 KDM4E (0.72) SMN1; SMN2KDM4ELMNACYP1A2CCR1
SCHEMBL4298850 0.79 TAAR1 (0.48) OPRD1KDM4ELMNACYP1A2CCR1
SCHEMBL2715731 0.78 SMN1; SMN2 (0.52) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL750061 0.78 KDM4E (0.62) SMN1; SMN2KDM4ELMNACYP1A2CCR1
SCHEMBL29730352 0.78 KDM4E (0.62) SMN1; SMN2KDM4ELMNACYP1A2CCR1
SCHEMBL5427655 0.77 LMNA (0.53) OPRD1KDM4ELMNACYP1A2CCR1
SCHEMBL8925746 0.77 CA1 (0.64) SMN1; SMN2LMNACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5453509-A Functionalization of acyl pyridinium salts SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1995-09-26 — — US disclosed
WO-1995010505-A1 FUNCTIONALIZATION OF ACYL PYRIDINIUM SALTS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1995-04-20 — — WO disclosed
Send feedback